Breast Cancer Clinical Trials in Men

Some people with #cancer will have only one #treatment. But most people have a combination of treatments, such as surgery with #chemotherapy and/or #radiation #therapy. When you need treatment for cancer, you have a lot to learn and think about.

Graft Guidance is issued by US #FDA encouraging the inclusion of male patients in #clinical #trials of breast cancer drugs. #Breast_cancer is rare in males, with less than 1% of all cases occurring in men. Men are not typically included in #clinical_trials for breast cancer treatment, which has led to a related lack of data. Men's treatments are generally based upon studies in #women, said the FDA in a press statement. Some approved treatments are gender-neutral in their indication, but many therapies are only approved for women and further data may be necessary to support labeling indications for men, the agency pointed out. The goal of the guidance is to provide additional #FDA-approved treatment options for men.

Recently, the FDA extended the indication of the breast cancer drug #palbociclib to include male patients, based on "real world" data. Post marketing reports and electronic health records showed that the safety profile for men treated with palbociclib was consistent with the safety profile for women. The decision was also based on the acknowledgement that the majority of breast tumors in male patients express hormone receptors; such #tumors are typically treated with endocrine-based therapies, which, in #advanced_cancers, may include palbociclib.

For more details please follow the link: https://frontiersmeetings.com/conferences/breastcancercongress/

For queries and details contact us: worldbreastcancer@globalbreastcancercongress.org